Dr. Reddy’s launches anti-osteoporosis drug in the US market
HYDERABAD, INDIA| Dr.Reddy’s Laboratories based in Hyderabad, India, on Monday said that it had launched Ibandronate Sodium, a drug for treatment of osteoporosis, in the US market. The said drug is to be sold More...
Lupin gets USFDA’s green signal for oral pregnancy pill
Indian pharma company based in Mumbai, Lupin Ltd, has received an approval from the US Food and Drug Administration, for marketing the generic version of oral contraceptive, Ortho Tri-cyclen Lo tablets in the US. The More...
BioSpecifics Technologies announces beginning of XIAFLEX® Phase II Trial
NEW YORK, USA| BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX® in Europe and Eurasia, announced recently More...
GW Pharmaceuticals seeks FDA permission for Sativex
Sativex, is the world’s first marijuana based prescription drug, developed by GW Pharmaceuticals, a British pharmaceutical company. This drug, developed as a mouth spray, has two best known psychoactive ingredients More...
FDA Grants clearance to a disinfecting port protector
Carlsbad, California (USA) – Ivera Medical Corporation today announced that it has received a new FDA 510(k) clearance for its Curos disinfecting port protector. The Curos passive disinfection cap first More...
Ranbaxy gets Green signal for Lipitor from US FDA
US Food and Drug Administration grants Ranbaxy Laboratories a final approval for Atrovastatin Calcium -Abbreviated New Drug Application (ANDA) in multiple strengths of 10 mg, 20 mg, 40 mg and 80 mg. Pfizer first More...